Skip to main content
. Author manuscript; available in PMC: 2009 Feb 1.
Published in final edited form as: Br J Ophthalmol. 2008 Oct 1;93(2):198–202. doi: 10.1136/bjo.2008.147298

Table 1.

Inclusion and Exclusion Criteria for the SCUT trial

Inclusion Criteria (All must be met)
  • Presence of a corneal ulcer at presentation (defined by an epithelial defect and signs of stromal inflammation)

  • Cornea culture on blood or chocolate agar indicates the presence of bacteria

  • Antibiotic given for ≥ 48 hours

  • The patient must be able to verbalise a basic understanding of the study after it is explained to the patient, as determined by a physician examiner. This understanding must include a commitment to return for follow-up visits.

  • Appropriate consent

Exclusion Criteria
  • Overlying epithelial defect < 0.75 mm at its greatest width at presentation

  • Impending perforation

  • Evidence of fungus on KOH or Giemsa stain at time of presentation

  • Evidence of acanthamoeba by stain

  • Evidence of herpetic keratitis by history or exam

  • History of corneal scar in the affected eye

  • Use of a topical steroid in the affected eye during the course of the present ulcer, including use after the symptoms of the ulcer started but before presentation

  • Use of systemic steroids during the course of the present ulcer

  • Age less than 16 years

  • Bilateral ulcers

  • Previous penetrating keratoplasty

  • Pregnancy (by history or urine test)

  • Outside 200 kilometer radius for Aravind

  • Evidence of fungus on culture at time of enrollment

  • Best spectacle-corrected vision worse than 6/60 (20/200) in the fellow eye

  • Corneal perforation or descemetocoele

  • Known allergy to study medications (steroid or preservative)

  • No light perception in the affected eye

  • Not willing to participate or to return for follow-up visits